Clinical Trial Update: TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) [Phase 3]

View source ↗

Summary

Phase 3 results for TREXIMET (sumatriptan/acetaminophen) in the acute treatment of migraine without aura have been completed, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine, Without Aura | Phase 3 | Status: COMPLETED | Results posted: 2009-07-10